Type your tag names separated by a space and hit enter

Zoledronate 5 mg every 18 months reduces fragility fractures in women over 65 with osteopenia (NNT = 15 over 6 years)

Zoledronate 5 mg every 18 months reduces fragility fractures in women over 65 with osteopenia (NNT = 15 over 6 years) is a topic covered in the EE+ POEM Archive.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

Slawson, David C., et al., editors. "Zoledronate 5 Mg Every 18 Months Reduces Fragility Fractures in Women Over 65 With Osteopenia (NNT = 15 Over 6 Years)." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314709/all/Zoledronate_5_mg_every_18_months_reduces_fragility_fractures_in_women_over_65_with_osteopenia__NNT_=_15_over_6_years_.
Zoledronate 5 mg every 18 months reduces fragility fractures in women over 65 with osteopenia (NNT = 15 over 6 years). In: Slawson DC, Shaughnessy AF, Ebell MH, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314709/all/Zoledronate_5_mg_every_18_months_reduces_fragility_fractures_in_women_over_65_with_osteopenia__NNT_=_15_over_6_years_. Accessed March 21, 2019.
Zoledronate 5 mg every 18 months reduces fragility fractures in women over 65 with osteopenia (NNT = 15 over 6 years). (2019). In Slawson, D. C., Shaughnessy, A. F., Ebell, M. H., & Barry, H. (Eds.), EE+ POEM Archive. Available from https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314709/all/Zoledronate_5_mg_every_18_months_reduces_fragility_fractures_in_women_over_65_with_osteopenia__NNT_=_15_over_6_years_
Zoledronate 5 Mg Every 18 Months Reduces Fragility Fractures in Women Over 65 With Osteopenia (NNT = 15 Over 6 Years) [Internet]. In: Slawson DC, Shaughnessy AF, Ebell MH, Barry H, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2019 March 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314709/all/Zoledronate_5_mg_every_18_months_reduces_fragility_fractures_in_women_over_65_with_osteopenia__NNT_=_15_over_6_years_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Zoledronate 5 mg every 18 months reduces fragility fractures in women over 65 with osteopenia (NNT = 15 over 6 years) ID - 1314709 ED - Slawson,David C, ED - Shaughnessy,Allen F, ED - Ebell,Mark H, ED - Barry,Henry, BT - EE+ POEM Archive UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314709/all/Zoledronate_5_mg_every_18_months_reduces_fragility_fractures_in_women_over_65_with_osteopenia__NNT_=_15_over_6_years_ PB - John Wiley & Sons DB - Evidence Central DP - Unbound Medicine ER -